HELSINN HLTHCARE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HELSINN HLTHCARE, and what generic alternatives to HELSINN HLTHCARE drugs are available?
HELSINN HLTHCARE has five approved drugs.
There are thirty-seven US patents protecting HELSINN HLTHCARE drugs.
There are three hundred and thirty-seven patent family members on HELSINN HLTHCARE drugs in fifty-eight countries and twenty-three supplementary protection certificates in fourteen countries.
Summary for HELSINN HLTHCARE
International Patents: | 337 |
US Patents: | 37 |
Tradenames: | 3 |
Ingredients: | 4 |
NDAs: | 5 |
Drugs and US Patents for HELSINN HLTHCARE
Expired US Patents for HELSINN HLTHCARE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | 5,202,333 | ⤷ Try a Trial |
Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 5,202,333 | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 9,125,905 | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 5,202,333*PED | ⤷ Try a Trial |
Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 6,297,375 | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 5,202,333*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HELSINN HLTHCARE Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Jordan | 3061 | ⤷ Try a Trial |
Poland | 2722045 | ⤷ Try a Trial |
Denmark | 1601359 | ⤷ Try a Trial |
Taiwan | I342212 | ⤷ Try a Trial |
Taiwan | 201605494 | ⤷ Try a Trial |
Croatia | P20161708 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for HELSINN HLTHCARE Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2785706 | CA 2020 00028 | Denmark | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT OG FARMACEUTISK ACCEPTABLE SALTE ELLER SOLVATER HERAF, SAERLLIGT FOSNETUPITANT KLORID HYDROKLORID; REG. NO/DATE: EU/1/15/1001 20200318 |
1035115 | CA 2015 00044 | Denmark | ⤷ Try a Trial | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150527 |
2785706 | C02785706/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022 |
2785706 | C20200029 00371 | Estonia | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT;REG NO/DATE: EU/1/15/1001; 18.03.2020 |
0430190 | SPC/GB05/032 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322 |
2785706 | 122020000050 | Germany | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.